1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
2Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
J Adolesc Young Adult Oncol. 2019 Aug;8(4):423-433. doi: 10.1089/jayao.2018.0144. Epub 2019 Apr 26.
Reasons for the relatively low rates of adolescent and young adults (AYA) enrollment in cancer clinical trials in the United States require further empirical examination. In addition to structural factors such as lack of access and insurance barriers, attitudes toward clinical trials may be important to consider. This study aimed to evaluate and validate the Pediatric Research Participation Questionnaire (PRPQ)-a measure of attitudes to clinical trials adapted for AYA (15-29) with cancer and their caregivers. One hundred twenty-four AYA and 94 caregivers completed the PRPQ-AYA and measures of clinical trial knowledge and developmental/emotional maturity. Factor analysis evaluated the PRPQ-AYA structure, interitem reliability was computed, and Pearson correlations examined associations of validation measures with factor scores and computed scores reflecting perceived barriers, perceived benefits, and decision balance. Confirmatory factor analysis did not confirm the prior PRPQ factor structure. Exploratory factor analysis suggested a new four-factor structure for: AYA (1) trust/mistrust, (2) barriers/costs, (3) support for participation, and (4) incentives; and caregivers (1) trust/access, (2) mistrust/costs, (3) support for participation, and (4) risks to AYA. Factor scores and barriers, benefits, and decision balance scores demonstrated acceptable interitem reliability and were significantly correlated with clinical trial knowledge and emotional maturity in the expected direction. PRPQ-AYA factor structure for AYA and caregivers varied and should be interpreted cautiously due to limited power. Simple solutions of perceived benefits, perceived barriers, and decision balance were reliable and valid and provide important information to address and engage AYA through the clinical trial informed consent process.
美国青少年和年轻成年人(AYA)参与癌症临床试验的比率相对较低,其原因需要进一步通过实证研究来检验。除了缺乏机会和保险障碍等结构性因素外,对临床试验的态度可能也是需要考虑的重要因素。本研究旨在评估和验证儿科研究参与问卷(PRPQ)- 一项针对癌症青少年和年轻成年人(15-29 岁)及其照顾者的临床试验态度的测量工具。124 名青少年和年轻成年人和 94 名照顾者完成了 PRPQ-AYA 和临床试验知识以及发展/情感成熟度的测量。因子分析评估了 PRPQ-AYA 的结构,计算了项目间的可靠性,Pearson 相关性分析了验证措施与因子得分以及反映感知障碍、感知益处和决策平衡的计算得分的相关性。验证性因子分析未证实先前的 PRPQ 因子结构。探索性因子分析表明,新的四因子结构为:青少年和年轻成年人(1)信任/不信任,(2)障碍/成本,(3)支持参与,和(4)激励;以及照顾者(1)信任/获得途径,(2)不信任/成本,(3)支持参与,和(4)对青少年和年轻成年人的风险。因子得分和障碍、益处和决策平衡得分具有可接受的项目间可靠性,与临床试验知识和情感成熟度呈预期方向的显著相关性。青少年和年轻成年人及其照顾者的 PRPQ-AYA 因子结构存在差异,由于样本量有限,应谨慎解释。感知益处、感知障碍和决策平衡的简单解决方案具有可靠性和有效性,为通过临床试验知情同意过程与青少年和年轻成年人进行沟通和参与提供了重要信息。